| Francine Sippel Llc | |
|
405 8th Ave Nw Suite 333 Aberdeen SD 57401-2762 | |
| (605) 225-3622 | |
| (605) 229-2719 |
| Full Name | Francine Sippel Llc |
|---|---|
| Speciality | Psychologist |
| Location | 405 8th Ave Nw, Aberdeen, South Dakota |
| Authorized Official Name and Position | Francine Sippel (OWNER) |
| Authorized Official Contact | 6052253622 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Francine Sippel Llc 405 8th Ave Nw Suite 333 Aberdeen SD 57401-2762 Ph: (605) 225-3622 | Francine Sippel Llc 405 8th Ave Nw Suite 333 Aberdeen SD 57401-2762 Ph: (605) 225-3622 |
| NPI Number | 1386785079 |
|---|---|
| Provider Enumeration Date | 02/08/2007 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 6800998378 |
|---|---|
| Medicare Enrollment ID | O20070301000494 |
News Archive
A new survey of American adults revealed that while most feel knowledgeable when it comes to heart health, many do not put their knowledge into practice. In fact, 81 percent of respondents reported feeling well-informed about ways to maintain heart health and almost nine out of 10 knew they could help reduce the risk of heart disease by exercising and maintaining a healthy diet.
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of cognitive impairment despite taking medication to lower their blood pressure, according to new research in the American Heart Association's journal Hypertension.
Researchers at The Wistar Institute have found a new way to force cancer cells to self-destruct. Low doses of one anti-cancer drug currently in development, called Gamitrinib, sensitize tumor cells to a second drug, called TRAIL, also currently in clinical development as part of an anticancer regimen.
Orexo AB and Boehringer Ingelheim announced today that Boehringer Ingelheim has selected a development candidate resulting from the worldwide exclusive research, development and commercialisation agreement which Boehringer Ingelheim had signed in November 2005 with Biolipox, a Swedish research-based pharmaceutical company acquired by Orexo in October 2007.
According to today's headlines, President Obama will head to Maine to continue efforts to sell the new health reform law. Meanwhile, his administration is ramping up education plans and efforts to smooth the shift.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386785079 | NPI | - | NPPES |
| 4993774 | Other | SD | BCBS |
| 6551982 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 435 (South Dakota) | Primary |
| Provider Name | Francine A Sippel |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1245315100 PECOS PAC ID: 3971504135 Enrollment ID: I20070131000129 |
News Archive
A new survey of American adults revealed that while most feel knowledgeable when it comes to heart health, many do not put their knowledge into practice. In fact, 81 percent of respondents reported feeling well-informed about ways to maintain heart health and almost nine out of 10 knew they could help reduce the risk of heart disease by exercising and maintaining a healthy diet.
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of cognitive impairment despite taking medication to lower their blood pressure, according to new research in the American Heart Association's journal Hypertension.
Researchers at The Wistar Institute have found a new way to force cancer cells to self-destruct. Low doses of one anti-cancer drug currently in development, called Gamitrinib, sensitize tumor cells to a second drug, called TRAIL, also currently in clinical development as part of an anticancer regimen.
Orexo AB and Boehringer Ingelheim announced today that Boehringer Ingelheim has selected a development candidate resulting from the worldwide exclusive research, development and commercialisation agreement which Boehringer Ingelheim had signed in November 2005 with Biolipox, a Swedish research-based pharmaceutical company acquired by Orexo in October 2007.
According to today's headlines, President Obama will head to Maine to continue efforts to sell the new health reform law. Meanwhile, his administration is ramping up education plans and efforts to smooth the shift.
› Verified 8 days ago
News Archive
A new survey of American adults revealed that while most feel knowledgeable when it comes to heart health, many do not put their knowledge into practice. In fact, 81 percent of respondents reported feeling well-informed about ways to maintain heart health and almost nine out of 10 knew they could help reduce the risk of heart disease by exercising and maintaining a healthy diet.
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of cognitive impairment despite taking medication to lower their blood pressure, according to new research in the American Heart Association's journal Hypertension.
Researchers at The Wistar Institute have found a new way to force cancer cells to self-destruct. Low doses of one anti-cancer drug currently in development, called Gamitrinib, sensitize tumor cells to a second drug, called TRAIL, also currently in clinical development as part of an anticancer regimen.
Orexo AB and Boehringer Ingelheim announced today that Boehringer Ingelheim has selected a development candidate resulting from the worldwide exclusive research, development and commercialisation agreement which Boehringer Ingelheim had signed in November 2005 with Biolipox, a Swedish research-based pharmaceutical company acquired by Orexo in October 2007.
According to today's headlines, President Obama will head to Maine to continue efforts to sell the new health reform law. Meanwhile, his administration is ramping up education plans and efforts to smooth the shift.
› Verified 8 days ago
Avera St Lukes Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 305 S State St, Aberdeen, SD 57401 Phone: 605-622-5000 Fax: 605-622-5255 | |
Prairie View Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2301 8th Ave Ne Ste 135, Aberdeen, SD 57401 Phone: 605-725-2230 | |
Northern State University Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1200 S Jay St, Aberdeen, SD 57401 Phone: 605-626-2566 | |
Lavonne Appletoft, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 405 8th Ave Nw Ste 333, Aberdeen, SD 57401 Phone: 605-225-3622 Fax: 605-229-2719 | |
Northern Plains Psychological Associates, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 405 8th Ave Nw Ste 333, Aberdeen, SD 57401 Phone: 605-225-3622 Fax: 605-229-2719 | |
Laurie Z Lippert Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 405 8th Ave Nw, Suite 333, Aberdeen, SD 57401 Phone: 605-225-3622 Fax: 605-229-2719 | |
Rebecca J Kuch Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 405 8th Ave Nw Ste 333, Aberdeen, SD 57401 Phone: 605-225-3622 Fax: 605-229-2719 |